CKBM stimulates MAPKs but inhibits LPS-induced IFN-γ in lymphocytes

Phytotherapy Research

Volumn 20, Issue 9, 2006, Pages 725-731

  Chan, Anthony S L ^a   Yip, Eric C H ^a   Yung, Lisa Y ^a   Pang, Haihong ^a   Luk, Sharon C W ^b   Pang, Shiu F ^b   Wong, Yung H ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b CK Life Sciences Int'l Holdings Inc   (Hong Kong)

Author keywords

B lymphocytes; Cytokines; IFN ; Immuno modulation; MAPK; T lymphocytes

Indexed keywords

CYTOKINE; FRUCTUS CRATAEGI EXTRACT; GAMMA INTERFERON; GINSENG EXTRACT; GLYCINE MAX EXTRACT; HERBACEOUS AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT; SCHINSANDRA CHINENSIS EXTRACT; SIGNAL PEPTIDE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZIZYPHUS JUJUBA EXTRACT;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHINESE MEDICINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; FRUCTUS CRATAEGI; GINSENG; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFLAMMATORY DISEASE; JUJUBE; MEDICINAL PLANT; PERIPHERAL BLOOD MONONUCLEAR CELL; SACCHAROMYCES CEREVISIAE; SCHINSANDRA CHINENSIS; SOYBEAN; T LYMPHOCYTE SUBPOPULATION; TIMED DRUG RELEASE;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; TIME FACTORS;

GLYCINE MAX; PANAX GINSENG; SACCHAROMYCES CEREVISIAE; SCHISANDRA CHINENSIS; ZIZIPHUS;

EID: 33748775736     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1943     Document Type: Article

References (30)

1. Aiken C, Chen CH. 2005. Betulinic acid derivatives as HIV-1 antivirals. Trends Mol Med 11: 31-36.
2. Bandyopadhyay G, Biswas T, Roy KC et al. 2004. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104: 2514-2522.
3. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B. 1999. TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs. FASEB J 13: 63-68.
4. Chan AS, Yeung WW, Wong YH. 2005a. Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells. J Neurochem 94: 1457-1470.
5. Chan AS, Yip EC, Yung LY et al. 2005b. Immuno-regulatory effects of CKBM on the activities of mitogen-activated protein kinases and the release of cytokines in THP-1 monocytic cells. Biol Pharm Bull 28: 1645-1650.
6. Chan BP, Yuen WF, Lee WH et al. 2004a. Immunomodulating effects of CKBM on the cytokine production in peripheral blood mononuclear cells (PBMCs) from healthy volunteers. Immunopharmacol Immunotoxicol 26: 177-192.
7. Chan JY, Cheung JY, Luk SC, Wu YJ, Pang SF, Fung KP. 2004b. Anti-cancer and pro-apoptotic effects of an herbal medicine and Saccharomyces cerevisiae product (CKBM-T01) on human hepatocellular carcinoma HepG2 cells in vitro and in vivo. Immunopharmacol Immunotoxicol 26: 597-609.
8. +-induced apoptosis in SHSY5Y cells. J Neural Transm 110: 835-845.
9. Constantin A, Loubet-Lescoulie P, Lambert N et al. 1998. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. Arthritis Rheum 141: 48-57.
10. Correll PH, Morrison AC, Lutz MA. 2004. Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol 75: 731-737.
11. Curran EM, Judy BM, Newton LG et al. 2004. Dietary soy phytoestrogens and ERα signalling modulate interferon-γ production in response to bacterial infection. Clin Exp Immunol 135: 219-225.
12. Fong WF, Tse AK, Poon KH, Wang C. 2005. Magnolol and honokiol enhance HL-60 human leukemia cell differentiation induced by 1,25-dihydroxyvitamin D3 and retinoic acid. Int J Biochem Cell Biol 37: 427-441.
13. Furuya Y, Kawakita T, Nomoto K. 2002. Participation of contrasting changes in IL-10 and IL-12 production in the reduction of Th1-predominance by Hachimi-jio-gan in autoimmune MRL/MP-lpr/lpr mice. Immunopharmacol Immunotoxicol 24: 17-29.
14. Ganapamo F, Dennis VA, Philipp MT. 2001. CD19(+) cells produce IFNγ in mice infected with Borrelia burgdorferi. Eur J Immunol 31: 3460-3468.
15. Ham YM, Choi JS, Chun KH, Joo SH, Lee SK. 2003. The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis. J Biol Chem 278: 50330-50337.
16. Hsu HY, Wen MH. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 277: 22131-22139.
17. Maes M, DeVos N, Wauters A et al. 1999. Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease. J Psychiatr Res 33: 397-405.
18. Maggiolini M, Vivacqua A, Fasanella G et al. 2004. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279: 27008-27016.
19. McLeish KR, Klein JB, Coxon PY, Head KZ, Ward RA. 1998. Bacterial phagocytosis activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in human neutrophils. J Leukoc Biol 64: 835-844.
20. Mizuno M, Yamada J, Terai H, Kozukue N, Lee YS, Tsuchida H. 1994. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem Biophys Res Commun 200: 1672-1678.
21. Pang JJ, Shan HM, Xu RK, Luk CW, Pang SF, Xu JN. 2004. Chang Ke Zhi Ji Zeng Qiang Shi Yan Dong Wu De Mian Yi Gong Leng. World Clin Drugs 25: 444-446, 448.
22. Ramana CV, Gil MP, Schreiber RD, Stark GR. 2002. Stat1-dependent and -independent pathways in IFNγ-dependent signaling. Trends Immunol 23: 96-101.
23. Shin VY, So WHL, Liu ESL, Wu YJ, Pang SF, Cho CH. 2004. Anti-tumorigenic and pro-apoptotic effects of CKBM on gastric cancer growth in nude mice. Int J Med Sci 1: 137-145.
24. Tan Y, Yu R, Pezzuto JM. 2003. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Clin Cancer Res 9: 2866-2875.
25. Tong Y, Zhang X, Zhao W et al. 2004. Anti-angiogenic effects of Shiraiachrome A, a compound isolated from a Chinese folk medicine used to treat rheumatoid arthritis. Eur J Pharmacol 494: 101-109.
26. van der Graaff WL, Prins AP, Niers TM, Dijkmans BA, van Lier RA. 1999. Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. Rheumatology (Oxford) 38: 214-220.
27. Vetvicka V, Thornton BP, Ross GD. 1996. Soluble β-glucan polysaccharide binding to the lectin site of neutrophil or natural killer cell complement receptor type 3 (CD11b/CD18) generates a primed state of the receptor capable of mediating cytotoxicity of iC3b-opsonized target cells. J Clin Invest 98: 50-61.
28. Wadsworth TL, McDonald TL, Koop DR. 2001. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol 62: 963-974.
29. Wang R, Tang XC. 2005. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals 14: 71-82.
30. Yang SH, Whitmarsh AJ, Davis RJ, Sharrocks AD. 1998. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J 17: 1740-1749.